[Controlled release metoprolol succinate in MERIT-HF. Analysis of patients subgroups]
Author(s): Sidorenko BA, Bugrimova MA, Iosava IK, Pataraia SA, Preobrazhenskii DV
Affiliation(s): Presidential Medical Center of Russia, Moscow, Russia.
Publication date & source: 2008, Kardiologiia., 48(3):85-8.
Publication type: English Abstract
Results of the investigation of metoprolol CR/XL which was conducted in large randomized controlled study MERIT-HF in patients with chronic heart failure (CHF) are presented. In the whole trial this beta1-selective blocker lowered mortality of patients with CHF. Analysis of results in subgroups shows that metoprolol CR/XL was equally effective in middle aged and old patients, in men and women.
|